| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.72B | 1.75B | 2.05B | 2.24B | 2.18B |
| Gross Profit | 630.76M | 693.60M | 840.29M | 771.00M | 855.37M |
| EBITDA | 54.87M | -48.64M | 42.42M | -289.44M | 32.07M |
| Net Income | 54.13M | -326.14M | -248.37M | -539.96M | -138.07M |
Balance Sheet | |||||
| Total Assets | 1.60B | 2.55B | 2.78B | 3.09B | 3.42B |
| Cash, Cash Equivalents and Short-Term Investments | 183.10M | 309.35M | 416.16M | 473.78M | 536.83M |
| Total Debt | 561.17M | 645.94M | 995.01M | 1.01B | 839.04M |
| Total Liabilities | 1.17B | 2.24B | 1.76B | 1.79B | 1.67B |
| Stockholders Equity | 425.22M | 305.83M | 1.02B | 1.30B | 1.76B |
Cash Flow | |||||
| Free Cash Flow | -14.09M | 28.99M | 16.15M | -164.27M | -190.88M |
| Operating Cash Flow | -10.06M | 96.46M | 141.81M | 12.15M | -1.71M |
| Investing Cash Flow | 33.52M | -92.11M | -77.14M | -182.11M | -959.06M |
| Financing Cash Flow | -148.98M | -22.91M | -122.29M | 106.92M | 724.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £2.85B | 2.38 | 21.64% | ― | -6.43% | 52.93% | |
73 Outperform | £1.38B | 23.58 | 5.88% | 1.18% | 9.51% | -31.96% | |
71 Outperform | £3.68B | 26.72 | 17.89% | 1.21% | 14.60% | 58.84% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
52 Neutral | £262.77M | -1.12 | -111.93% | ― | -14.89% | 12.08% | |
50 Neutral | £655.51M | 11.73 | 12.75% | ― | -20.36% | 44.33% | |
41 Neutral | £256.66M | -3.32 | -9999.00% | ― | -65.42% | 27.73% |